[Pirenzepine parenterally administered in high doses in the treatment of upper digestive hemorrhage]. 1984

P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei

22 patients with moderate and severe haemorrhages of the UAC were given endovenous doses of Pirenzepine (100 mg/48 hrs). The drug was effective in 86% of the cases and its effect on pH values was demonstrated by testing before and after administration (p less than 0.01). Better results were observed in the treatment of patients with moderate and severe DUS.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010890 Pirenzepine An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Gastrotsepin,Gastrozepin,L-S 519,LS-519,Piren-Basan,Pirenzepin,Pirenzepin Von Ct,Pirenzepin-Ratiopharm,Pirenzepine Dihydrochloride,Pyrenzepine,Ulcoprotect,Ulgescum,Dihydrochloride, Pirenzepine,LS 519,LS519,Piren Basan,Pirenzepin Ratiopharm,Von Ct, Pirenzepin
D004382 Duodenitis Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER. Erosive Duodenitis,Duodenitis, Erosive
D005260 Female Females
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
January 1986, Minerva dietologica e gastroenterologica,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
January 1987, Minerva dietologica e gastroenterologica,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
January 1982, G.E.N,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
October 1988, Minerva chirurgica,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
March 1987, American journal of veterinary research,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
January 1979, G.E.N,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
January 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
February 1985, Minerva medica,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
December 1977, Revue medicale de Liege,
P Chirletti, and P Colobraro, and R Romano, and A Barzi, and N Mangialardi, and I Bertoldi, and P Valentini, and A Cirenei
December 1994, Revista espanola de enfermedades digestivas,
Copied contents to your clipboard!